Thrive Capital
Multistage venture firm; HQ New York City; founded 2010 by Joshua Kushner. Notable AI portfolio: OpenAI, Cursor, Scale AI, Anthropic. Other portfolio: Stripe, Instagram (early), Spotify, GitHub.
Console Relevance
- Led Console’s $6.2M seed (Jun 2, 2025).
- Co-led Console’s $23M Series A with DST Global Partners (Sep 2025; ~3 months after seed).
- Deal partner: Vince Hankes (Partner at Thrive Capital). Hankes has had a thesis about AI’s potential to assist with IT tasks since ChatGPT was first released. Thrive’s prior AI portfolio (OpenAI, Cursor, Scale AI) is the natural progression.
Related
Fundraise intel (2026-05-25)
Conflict status: HARD-CONFLICTED (Console lead, both rounds)
Thrive Capital is structurally locked out of init.inc’s raise. It is the single deepest competitor cap-table tie in init.inc’s funnel: Thrive led the seed AND co-led the Series A of Console — a direct AI-ITSM/IT-helpdesk competitor (Slack-native AI IT assistant that auto-resolves >50% of IT requests; founder Andrei Serban, ex-Rippling). Per the cap-table synthesis, this is “Lead × 2 (same competitor)” — the second-highest-pressure conflict class after a firm leading two distinct competitors.
- Console seed — $6.2M, Jun 2, 2025 — Thrive LED (sole lead named). Deal partner Vince Hankes. (TechCrunch)
- **Console Series A — 22M”; TechCrunch + body text say **23M (matches existing synthesis).
Why this is full-stop, not partner-conflict: Console is a thesis bet for Thrive — Hankes has publicly said Thrive “has had a thesis about AI’s potential to assist with IT tasks since ChatGPT was first released.” That makes the IT-agent wedge a firm-narrative commitment, not one partner’s side deal. A lead-investor partner has board attention and a thesis to defend (per the lead-vs-follower doctrine in the synthesis). No clean Thrive partner exists for init.inc on this wedge — see below.
Firm profile
Multistage venture firm; HQ New York City; founded 2010 by Joshua Kushner. Raised a $10B new fund Feb 2026 (Advisor Perspectives) — large, late-leaning multistage capital base. Flagship AI portfolio: OpenAI, Cursor, Scale AI, Anthropic; broader: Stripe, Instagram (early), Spotify, GitHub. NOTE: distinct from thrivenextgen.com (the Court Square-backed MSP rollup) — different entity entirely.
Partners (POCs)
- Vince Hankes — Partner; the Console deal partner (both rounds). Ex-Tiger Global. Owns the AI-IT thesis at Thrive — the conflict driver.
- Kareem Zaki — Partner; co-founds portfolio companies (e.g. Cadence Health). Enterprise/healthcare-leaning; no public IT-agent tie ^[inferred] — but firm-level Console conflict applies.
- Gaurav Ahuja — left Thrive Jan 2026 after 7 years; raising his own ~$30M seed fund “Timeless” (PitchBook). No longer a Thrive path; a separate-entity fund. ^[single-source]
Any partner still clean for init.inc?
No clean partner at Thrive. Unlike a follower-conflict firm, Thrive’s exposure is a firm-thesis lead position in a direct competitor. Even partners with no personal Console tie (Zaki) sit under the same IC and the same “AI-for-IT” house view Hankes articulated publicly. The only separate-entity adjacency is Gaurav Ahuja’s new solo fund (post-Thrive) — unverified thesis fit, tiny vs. init’s ~$7M target.
Best data channels for this firm
TechCrunch + Upstarts (Mario Gabriele) are the most reliable on the Console rounds — both quote Hankes directly. Thrive does not publish a deal blog; partner attribution comes from the announcement bodies, not a firm site. NFX Signal has Hankes’s deal history. The Venture Codex understates co-lead role (would likely call the Series A “Thrive led” and drop the DST co-lead). For the $10B fund / firm-mechanics: WSJ/Advisor Perspectives.
Fundraise Relationship (init.inc)
- Status: ⚠️ Hard-conflicted via the Console lead position; closed on entry. Thrive is the canonical “incumbent’s chosen challenger” for how a top multistage prices the AI-ITSM wedge.
- Conversation log (from CRM, newest first):
- 2026-04-24 — Logged Conflicted. POC Mohit Agarwal (intro via Kushal / Mohit). Note: “Conflicted — Thrive invested in Console (competitor in our space).” No live process; closed on entry.
- Mutual connections / warm path: Mohit (CRM connector) + Kushal sourced the Mohit Agarwal POC. ⚠️ Disambiguation: the CRM “Mohit Agarwal” is the Thrive-side POC; the connector node Mohit is a separate friend-of-company. Keep distinct.
- Personal & rapport notes: Thrive culture is concentrated-bets, high-conviction, founder-CEO-led (Kushner). They go big and back the category winner — which is exactly why a competitor lead position is so sticky.
- Live stage: Conflicted (CRM) — not a live deal.
Cross-check vs existing wiki
- Agrees with the existing page body (Console seed lead + Series A co-lead; Hankes deal partner) and with
synthesis/cap-table-patternswhich lists Thrive as “Console (seed lead + Series A co-lead) — Lead × 2 (same competitor).” No contradictions. - The existing frontmatter
relationship: competitor-investoris consistent with this fundraise read; for the raise lens this is a fundraise-firm-dead / conflicted firm. (Frontmatter left unchanged per append-only rule.) - Synthesis “soft-flag” note: Thrive is also among Sabrina Hahn’s SH Fund LPs (Hahn = Serval angel) — LP-level, not additive to the direct Console conflict.
Pass 2 deal pattern (2026-05-25)
Pass-2 deal pull (CONFLICTED tier, MODERATE depth). Conflict-surface-first. Double-verified (Exa CLI + Claude WebSearch). Full data → /Users/sazzad14/seed-market-scan/firms/thrive-capital.csv (6 rows). Content above this line unchanged.
Conflict surface (exhaustive — the priority)
Swept Thrive’s portfolio against all 16 init.inc competitors (Serval, Console, Atomicwork, STLabs, Edra, Treeline, Risotto, Risotto, Ravenna, Echelon, Siit, Modern, QueryPal, Wrangle, Rezolve, ClearFeed, Unthread) AND the close-adjacent surface (AI-ITSM / agentic-IT / back-office-automation / services-as-software). Sources: Tracxn + Refolk + WhiteRose portfolio trackers, aifunding.me, TechCrunch, CNBC, GV blog.
- DIRECT competitor exposure = Console ONLY — and it is the deepest in the funnel: seed lead (23M, Sep 2025) = “Lead × 2 (same competitor)”, the highest-pressure conflict class. Deal partner Vince Hankes both rounds; Thrive’s “AI for IT” house thesis. No change from Pass 1 — re-confirmed.
- No other roster competitor found on Thrive’s cap table. Serval, Atomicwork, STLabs, Edra, Treeline, Risotto, Ravenna, Echelon, Siit, Modern, QueryPal, Wrangle, Rezolve, ClearFeed, Unthread — all NO across two independent portfolio trackers (Tracxn, Refolk) + the Serval/STLabs/Atomicwork announcement investor lists (none name Thrive). ✅
- One close-adjacent (NOT a direct conflict): Sierra ^[needs-page] (Bret Taylor / Clay Bavor) — enterprise AI agents for customer service + back-office = services-as-software / AI-employee thesis, but CX-anchored, not AI-ITSM/IT-helpdesk. Thrive entered as a participant in the Oct-2024 950M Series E — contradicted by CNBC + TechCrunch, which name Tiger Global + GV as the Series E leads and Thrive as a prior investor. Net: Sierra is an adjacency flag on the services-as-software thesis, not an additive ITSM conflict. (Aligns with the synthesis note that the “next ServiceNow” consensus is forming via the broader enterprise-agent wedge.)
Net conflict surface: single direct competitor (Console), maximal posture (lead × 2). HARD-CONFLICTED — re-confirmed from Pass 1.
Representative recent seed pattern (moderate)
Thrive is not a classic small-seed shop — it is a late-leaning multistage firm running a 2.1B Series B led, May 2026; OpenAI/Cursor/Databricks/Perplexity leads). The $6.2M Console seed is the exception, not the cadence — a thesis-conviction seed by Hankes into the AI-IT wedge, not a representative seed-cadence data point. Thrive does seeds only as high-conviction thesis entries it intends to own through later rounds (exactly what happened with Console: seed → A in 3 months) — any Thrive seed is a structural lead/own position, with no “small participant” lane.
Per-partner clean map
| Partner | Conflict status | Clean lane for init.inc? |
|---|---|---|
| Vince Hankes | ⚠️ HARD — owns the Console lead (both rounds) + the AI-IT house thesis | No — the conflict driver |
| Kareem Zaki | Firm-level Console conflict; enterprise/healthcare-leaning; no personal IT-agent tie ^[inferred] | No — same IC + same house “AI-for-IT” view |
| Gaurav Ahuja | Left Thrive Jan 2026; raising own ~$30M seed fund “Timeless” | n/a at Thrive; separate-entity fund (unverified fit, tiny vs init’s target) ^[single-source] |
No partner clean at Thrive. The exposure is a firm-thesis lead position; even a personally-unconflicted partner sits under the same IC and the same publicly-stated “AI for IT” house view. The only separate-entity adjacency is Ahuja’s post-Thrive solo fund.
Best data channel
For Thrive’s conflict-relevant deals: TechCrunch + Upstarts (Mario Gabriele) on Console (both quote Hankes); CNBC/TechCrunch on Sierra (over the GV blog, which got the Series E lead wrong). Thrive publishes no deal blog — partner attribution comes from announcement bodies + NFX Signal (Hankes deal history). Portfolio trackers (Tracxn, Refolk) are reliable for the negative check (confirming Thrive did NOT back the other competitors). Firm-mechanics ($10B fund): WSJ / Advisor Perspectives.
COULDN’T-GET
- Exact round-level amounts/dates for Thrive’s OpenAI positions (multi-round, not pinned) — firm-posture context only, ❓.
- Whether Thrive holds any undisclosed stealth/seed agentic-IT position — portfolio trackers are necessarily incomplete on unannounced seeds; the negative finding is “no public evidence,” not a proof of absence ^[inferred].